Filter News
Area of Research
- Biological Systems (1)
- Biology and Environment (22)
- Clean Energy (10)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (1)
- Fusion Energy (1)
- Isotopes (5)
- Materials (14)
- Materials for Computing (4)
- National Security (4)
- Neutron Science (16)
- Nuclear Science and Technology (6)
- Supercomputing (72)
News Topics
- (-) Biomedical (58)
- (-) Molten Salt (8)
- (-) Quantum Computing (34)
- (-) Summit (57)
- 3-D Printing/Advanced Manufacturing (121)
- Advanced Reactors (34)
- Artificial Intelligence (91)
- Big Data (53)
- Bioenergy (91)
- Biology (98)
- Biotechnology (22)
- Buildings (57)
- Chemical Sciences (63)
- Clean Water (29)
- Climate Change (99)
- Composites (26)
- Computer Science (187)
- Coronavirus (46)
- Critical Materials (26)
- Cybersecurity (35)
- Decarbonization (79)
- Education (4)
- Element Discovery (1)
- Emergency (2)
- Energy Storage (108)
- Environment (194)
- Exascale Computing (37)
- Fossil Energy (5)
- Frontier (42)
- Fusion (54)
- Grid (62)
- High-Performance Computing (84)
- Hydropower (11)
- Irradiation (3)
- Isotopes (53)
- ITER (7)
- Machine Learning (47)
- Materials (144)
- Materials Science (140)
- Mathematics (7)
- Mercury (12)
- Microelectronics (3)
- Microscopy (51)
- Nanotechnology (60)
- National Security (61)
- Net Zero (13)
- Neutron Science (131)
- Nuclear Energy (108)
- Partnerships (44)
- Physics (61)
- Polymers (33)
- Quantum Science (69)
- Renewable Energy (2)
- Security (24)
- Simulation (47)
- Software (1)
- Space Exploration (25)
- Statistics (3)
- Sustainable Energy (125)
- Transformational Challenge Reactor (7)
- Transportation (97)
Media Contacts
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
To better understand the spread of SARS-CoV-2, the virus that causes COVID-19, Oak Ridge National Laboratory researchers have harnessed the power of supercomputers to accurately model the spike protein that binds the novel coronavirus to a human cell receptor.
A multi-institutional team became the first to generate accurate results from materials science simulations on a quantum computer that can be verified with neutron scattering experiments and other practical techniques.
Thirty-two Oak Ridge National Laboratory employees were named among teams recognized by former DOE Secretary Dan Brouillette with Secretary’s Honor Awards as he completed his term. Four teams received new awards that reflect DOE responses to the coronavirus pandemic.
Since the 1930s, scientists have been using particle accelerators to gain insights into the structure of matter and the laws of physics that govern our world.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.